Brand Name:

MYRICA GV 2.2

MYRICA GV 2.2 Tablet | Glimepiride 2 mg + Metformin 500 mg SR + Voglibose 0.2 mg

Categories:

TABLETS
Cardiac Diabetic
Contains Glimepiride 2 mg Contains Metformin 500 mg SR Contains Voglibose 0.2 mg Triple-combination therapy for Type 2 Diabetes Supports insulin secretion Helps improve insulin sensitivity Helps reduce hepatic glucose production Helps manage post-meal blood glucose levels Sustained-release Metformin formulation
MYRICA GV 2.2 Tablet combines Glimepiride 2 mg, Metformin 500 mg SR, and Voglibose 0.2 mg for blood glucose management in adults with Type 2 Diabetes. Glimepiride supports insulin release, Metformin helps improve insulin sensitivity and reduce hepatic glucose production, while Voglibose delays carbohydrate digestion and helps control post-meal glucose levels. Take only as prescribed by your healthcare professional.
Glimipride 2 Mg, Metformin 500 Mg (Sr) Voglibose 0.2 Mg

Contact Us To Accelerate Your Journey To Market